$ARRT
Artisan Consumer Goods, Inc.

2024 Q4 Form 10-Q Financial Statement

#000147793224006357 Filed on October 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $12.19K
YoY Change 105.46%
Operating Profit -$12.19K
YoY Change 105.46%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.502K
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$8.692K
YoY Change 46.45%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 4.400M shares 4.400M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.263K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $1.263K
YoY Change -91.76%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $1.000K
YoY Change 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.000K
YoY Change -70.37%
TOTAL ASSETS
Total Short-Term Assets $1.263K
Total Long-Term Assets $1.000K
Total Assets $2.263K
YoY Change -87.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $35.02K
YoY Change -33.26%
Accrued Expenses $42.86K
YoY Change -11.19%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $288.5K
YoY Change 1.46%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $288.5K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$19.29M
YoY Change 0.11%
Common Stock $4.400K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$286.3K
YoY Change
Total Liabilities & Shareholders Equity $2.263K
YoY Change -87.9%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$8.692K
YoY Change 46.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.53K
YoY Change 503.55%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $10.00K
YoY Change -33.33%
NET CHANGE
Cash From Operating Activities -$10.53K
Cash From Investing Activities
Cash From Financing Activities $10.00K
Net Change In Cash -$532.00
YoY Change -104.01%
FREE CASH FLOW
Cash From Operating Activities -$10.53K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
490 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
3700 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1263 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
4400 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2024Q3 arrt Stock Shares Subscribed But Unissued Value
StockSharesSubscribedButUnissuedValue
10973 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-286280 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
210 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
10350 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
490 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
1795 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
33694 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46358 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
280718 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19285853 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
490 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1263 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
0 usd
CY2024Q3 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2024Q3 us-gaap Other Assets
OtherAssets
1000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
35021 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42856 usd
CY2024Q3 arrt Due To Related Party Current
DueToRelatedPartyCurrent
210666 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
288543 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9000 usd
CY2024Q3 us-gaap Assets
Assets
2263 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2263 usd
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001530425
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4400048 shares
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
000-54838
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
ARTISAN CONSUMER GOODS, INC.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1240056
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
999 N Northlake Way Ste 203
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98103-3442
CY2024Q3 dei City Area Code
CityAreaCode
206
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
517-7147
CY2024Q3 dei Security12b Title
Security12bTitle
Common
CY2024Q3 dei Trading Symbol
TradingSymbol
ARRT
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4400048 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1795 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8875 usd
CY2024Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
125 usd
CY2024Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
1000 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
1125 usd
CY2024Q2 us-gaap Assets
Assets
2920 usd
CY2024Q2 arrt Due To Related Party Current
DueToRelatedPartyCurrent
200666 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
4400 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
18984200 usd
CY2024Q2 arrt Stock Shares Subscribed But Unissued Value
StockSharesSubscribedButUnissuedValue
10763 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19277161 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-277798 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2920 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1509 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
995 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
750 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
12194 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5935 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12194 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5935 usd
CY2024Q3 us-gaap Other Income
OtherIncome
3502 usd
CY2023Q3 us-gaap Other Income
OtherIncome
0 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3502 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8692 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5935 usd
CY2024Q3 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2023Q3 arrt Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2024Q3 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2023Q3 arrt Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
4400048 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-260253 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
490 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5935 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-265698 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-277798 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
210 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8692 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-286280 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-8692 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5935 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
750 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
210 usd
CY2024Q3 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
3502 usd
CY2023Q3 us-gaap Equity Fair Value Adjustment
EquityFairValueAdjustment
0 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1327 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2950 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10532 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1745 usd
CY2024Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10000 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-532 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
13255 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1795 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2067 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1263 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15322 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company provides estimates for its common stock valuations and valuation allowances for deferred taxes.</p>
CY2024Q3 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
11250 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
210 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19285853 usd
CY2024Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
9000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
750 usd
CY2024Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3502 usd
CY2023Q3 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2024Q3 arrt Due From Related Party
DueFromRelatedParty
210666 usd
CY2023Q3 arrt Due From Related Party
DueFromRelatedParty
200666 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4400048 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares

Files In Submission

Name View Source Status
0001477932-24-006357-index-headers.html Edgar Link pending
0001477932-24-006357-index.html Edgar Link pending
0001477932-24-006357.txt Edgar Link pending
0001477932-24-006357-xbrl.zip Edgar Link pending
arrt-20240930.xsd Edgar Link pending
arrt_10q.htm Edgar Link pending
arrt_ex311.htm Edgar Link pending
arrt_ex312.htm Edgar Link pending
arrt_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
arrt-20240930_cal.xml Edgar Link unprocessable
arrt-20240930_def.xml Edgar Link unprocessable
arrt-20240930_lab.xml Edgar Link unprocessable
arrt-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
arrt_10q_htm.xml Edgar Link completed